首页> 外文期刊>Neuropsychologia >Decisions under risk in Parkinson's disease: Preserved evaluation of probability and magnitude
【24h】

Decisions under risk in Parkinson's disease: Preserved evaluation of probability and magnitude

机译:帕金森氏病风险中的决策:概率和幅度的保留评估

获取原文
获取原文并翻译 | 示例
       

摘要

Introduction: Unmedicated Parkinson's disease patients tend to be risk-averse while dopaminergic treatment causes a tendency to take risks. While dopamine agonists may result in clinically apparent impulse control disorders, treatment with levodopa also causes shift in behaviour associated with an enhanced response to rewards. Two important determinants in decision-making are how subjects perceive the magnitude and probability of outcomes. Our objective was to determine if patients with Parkinson's disease on or off levodopa showed differences in their perception of value when making decisions under risk. Methods: The Vancouver Gambling task presents subjects with a choice between one prospect with larger outcome and a second with higher probability. Eighteen age-matched controls and eighteen patients with Parkinson's disease before and after levodopa were tested. In the Gain Phase subjects chose between one prospect with higher probability and another with larger reward to maximize their gains. In the Loss Phase, subjects played to minimize their losses. Results: Patients with Parkinson's disease, on or off levodopa, were similar to controls when evaluating gains. However, in the Loss Phase before levodopa, they were more likely to avoid the prospect with lower probability but larger loss, as indicated by the steeper slope of their group psychometric function (t(24)=2.21, p=0.04). Modelling with prospect theory suggested that this was attributable to a 28% overestimation of the magnitude of loss, rather than an altered perception of its probability. Conclusion: While pre-medicated patients with Parkinson's disease show risk-aversion for large losses, patients on levodopa have normal perception of magnitude and probability for both loss and gain. The finding of accurate and normally biased decisions under risk in medicated patients with PD is important because it indicates that, if there is indeed anomalous risk-seeking behaviour in such a cohort, it may derive from abnormalities in components of decision making that are separate from evaluations of size and probability.
机译:简介:未经药物治疗的帕金森氏病患者倾向于规避风险,而多巴胺能治疗则倾向于冒险。尽管多巴胺激动剂可能导致临床上明显的冲动控制障碍,但用左旋多巴治疗也会引起行为转变,与对奖赏的反应增强有关。决策中的两个重要决定因素是受试者如何看待结果的大小和可能性。我们的目的是确定左旋多巴内外帕金森氏病患者在风险决策中是否表现出对价值观念的差异。方法:Vancouver Gambling任务为受试者提供了一个选择,一个结果更大,另一个可能性更高。测试了十八例年龄匹配的对照和十八例左旋多巴前后的帕金森氏病患者。在收益阶段,受试者在一个可能性较高的前景和另一个收益较大的前景之间进行选择,以最大程度地获得收益。在损失阶段,受试者尽量减少损失。结果:在评估收益时,左旋多巴上或下的帕金森氏病患者与对照组相似。然而,在左旋多巴之前的丧失阶段,他们更有可能以较低的概率避开前景,但损失更大,这是由他们的小组心理测度函数的斜率更陡峭表示的(t(24)= 2.21,p = 0.04)。使用前景理论进行建模表明,这是由于对损失幅度的高估了28%,而不是对损失概率的看法有所改变。结论:尽管帕金森氏病的药物治疗前患者对大的损失表现出规避风险,但左旋多巴的患者对大小和损失及获得的可能性有正常的认识。在药物治疗的PD患者中发现有风险的准确且通常有偏见的决策很重要,因为它表明,如果在这样的队列中确实存在异常的风险寻求行为,则可能是由于决策成分与大小和概率的评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号